SNMMI Curriculum Videos

PSMA Targeted PET Imaging of Prostate Cancer, An SNMMI Webinar - Frankis Almaguel & Michael Gorin

Appropriate Use Criteria for PSMA PET Imaging - Hossein Jadvar

Imaging Prostate Cancer with F18 Fluciclovine PET - Neha Maithel & Isis Gayed

PSMA-targeted PET Imaging of Prostate Cancer - A Primer for Urologists - Michael Gorin

Symposium Discussion on PSMA-Targeted PET Imaging and Interpretation - What Urologists Need to Know

PSMA-Targeted PET Imaging Metastatic Disease, Response Assessment, Future Directions, and Read Paradigms - Steven Rowe

Radium-223 Treatment for Metastatic Prostate Cancer - Ila Sethi

Lutetium-177 PSMA: A Closer Look at Its Therapeutic Potential and Side Effects - Bennett Chin

Imaging With Fluciclovine for Prostate Cancer - Bital Savir-Baruch

PSMA Theranostics in Prostate Cancer SNMMI - Richard Baum

Discussion from Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium

PSMA-Based Diagnostic and Theranostic Strategies in Metastatic Prostate Cancer - Rahul Aggarwal

Integrating PSMA-based Fluorescence Molecular Imaging During Robotic Prostatectomy - Hao Nguyen

Introduction to PET PSMA Gallium-68 PSMA-11 for Diagnostic Imaging of Prostate Cancer - Tom Hope

Management of Oligometastatic Prostate Cancer: From Imaging to Therapy - Felix Feng

Changing the Standard of Care in Prostate Cancer with Advances in Nuclear Medicine, PET and Theranostics Symposium - Rob Flavell

Modulation of PSMA Expression by Androgen Deprivation Therapy (ADT) - Louise Emmett

Bone Targeted Theranostics with 18F-NaF/ 223Ra Cl2 in Prostate Cancer - Hossein Jadvar

Non-PSMA Based Theranostics in Prostate Cancer - Andrei Iagaru

Radiotherapy Planning in Prostate Cancer Patients - Matteo Sepulcri and Laura Evangelista

Reproducibility and Repeatability of Quantitative FDHT Uptake Metrics in CRPC - Andrew Scott

Early Initiation of Lu177 PSMA Radioligand Therapy Prolongs Survival in Metastatic PCa - Harshad Kulkarni

Initial Experience with Actinium- 225 PSMA in Advanced Prostate Cancer - Machaba Michael Sathekge

Prognostic Value of Baseline Imaging Parameters Prior to LuPSMA Therapy - Justin Ferdindandus

Radium 223 Dichloride Use in Patients with Castrate Resistant Prostate Cancer - Hossein Jadvar

SNMMI Osseous Scintigraphy - Ephraim E. Parent

Case-based Approaches: PSMA and Personalized Prostate Cancer Care - Frankis Almaguel

Bombesin - A New Frontier for Prostate Cancer Imaging - Andrei Iagaru

PSMA Theranostics and Personalized Prostate Cancer Care- Frankis Almaguel

PET C-11 Choline Imaging in Prostate Cancer Patients with Biochemical Recurrence- Ajit H. Goenka

Prostate Cancer Diagnosis and Treatment: Incorporating New PET imaging and Theranostic Approaches - Robert Flavell

18F-fluciclovine PET/CT in Patients with Suspected Recurrent Prostate Cancer - Bital Savir-Baruch